Issues
Optimization of radiotherapy combined course for rectal cancer
«Radiation and Risk», 2022, vol. 31, No. 2, pp.128-136
DOI: 10.21870/0131-3878-2022-31-2-128-136
Authors
Grigorieva A.A. – PhD Student, Research EngineerBulavskaya A.A. – Research Assistant, С. Sc., Phys.-Math.
Nguyen Tuan Anh – PhD Student
Stuchebrov S.G. – Associate Prof., С. Sc., Phys.-Math. NRTPU.
Startseva Zh.A. – Head Dep., MD, Prof. RAS
Velikaya V.V. – Re-searcher, С. Sc., Med.
Turgunova N.D. – Medical Physicist. CRI of Tomsk NRMC.
Miloichikova I.A. – Medical Physicist, С. Sc., Phys.-Math. NRTPU, CRI of Tomsk NRMC. Contacts: 5 Kooperativny Str., Tomsk, 634009. Tel.: +7 (3822) 282686 (ext. 3149); e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it. .
1 National Research Tomsk Polytechnic University, Tomsk
2 Cancer Research Institute of Tomsk National Research Medical Centre of the RAS, Tomsk
Abstract
Due to the new rapidly developed technological equipment for radiotherapy available in cancer clinics, the study of the optimal combination of topometric preparation of a patient with planning and the delivery of treatment in order to achieve the main goal of radiation therapy – maximum exposure of the foci with minimal damage to healthy tissue. The reduction of dose to critical organs and healthy tissues in general is an important and urgent task. The purpose of the paper is to explore the possi-bility of optimization of the combined radiation therapy in patients with rectal cancer, with account of advanced approaches to topometric preparation of a patient and dosimetry planning. Six patients 47-59 years of age, with the stage III of the lower ampullary rectal cancer, received two-phase pre-operative combined radiotherapy at the Tomsk Cancer Research Institute NMRC. The Phase 1 – distant radiation therapy delivery in standard mode with a single focal dose (ROD) of 2 Gy, 5 times a week, totally 20 fractions, to focal dose (SOD) of 40 Gy. The Phase 2 – intracavitary radiation therapy, ROD – 3 Gy, SOD – 15 Gy, locally in the tumor area, 2 times a week, total number – 5 fractions. The conventional radiation therapy planning was carried out with the use of the XiO 3-D dosimetry plan-ning system for the "Theratron Equinox 80" (radiation of the isotope 60Co, Ey=1.25 MeV), gamma-therapeutic apparatus, and for the SL75-5-MT (Electron braking radiation, E=6 MeV) linear accelerator. For conformal radial therapy the planning system for linear accelerator «Elekta Synergy» (elec-tron brake radiation, E=6 MeV) is used. For intracavitary radiotherapy the dosimetry planning system HDRPlus for the apparatus "MultiSource" (radiation of isotope 60Co, Ey=1.25 MeV) is used. Radiation doses to critical organs of patients with lower ampullary rectal cancer exposed to combined course of radiotherapy was calculated. It has been shown that the use of advanced techniques for pretreatment topometric preparation of a patient and dosimetry planning makes possible optimization of combined radiotherapy with account of radiation doses to critical organs.
Key words
external-beam radiotherapy, brachytherapy, combined radiotherapy course, rectal cancer, conventional radiotherapy, conformal radiotherapy, dosimetry planning, linear-quadratic model, gamma-teletherapy apparatus, clinical linear accelerator.
References
1. Dubovichenko D.M., Val’kov M.Yu., Merabishvili V.M., Karpunov A.A., Shcherbakov A.M., Val’kova L.E., Pankrat’yyeva A.Yu. Rectal cancer incidence and mortality (literature review and own research). Voprosy onkologii – Problems in Oncology, 2019, vol. 65, no. 6, pp. 816-824. (In Russian).
2. The status of cancer care for the population in Russia in 2019. Eds.: A.D. Kaprin, V.V. Starinskiy, G.V. Pe-trova. Moscow, NMRRC, 2019. 239 p. (In Russian).
3. Clinical practice guide: rectal cancer. Available at: https://oncology-association.ru/wp-content/up-loads/2020/09/rak_prjamoj_kishki.pdf (Accessed 03.09.2021). (In Russian).
4. Afanas’yev S.G., Tarasova A.S., Startseva Zh.A. Experience in the use of intracavitary radiation therapy in the treatment of lower ampullar cancer of the rectum. Povolzhskiy onkologicheskiy vestnik – Oncology Bulletin of the Volga Region, 2013, no. 2, pp. 28-32 (In Russian).
5. Trufanov G.E., Asaturyan M.A., Zharinov G.M. Radiation therapy. V. 2. Moscow, GEOTAR-Media Publ., 2010. 192 p. (In Russian).
6. Klimanov V.A. Dosimetric planning of radiation therapy. Part 1. Radiobiological bases of radiation therapy. Radiobiological and dosimetric planning of remote radiation therapy with bremsstrahlung and gamma beams and electrons. Guide. Moscow, NIYAU MIFI Publ., 2011. 500 p. (In Russian).
7. Stuchebrov S.G., Miloichikova I.A., Shilova X.O. The dosimetric parameters investigation of the pulsed X-ray and gamma radiation sources. J. Phys. Conf. Ser., 2016, vol. 671, no. 1, p. 012051. DOI: 10.1088/1742-6596/671/1/012051.
8. Rod’ko I.I., Sarychev G.A., Balakirev P.V., Bondarenko T.V., Dergacheva I.L., Evteev A.S., Cherednichenko D.V. Development of a radiation therapy complex based on a 6 MeV linear electron accel-erator and a cone-beam computed tomograph. Atomnaya energiya – Atomic Energy, 2018, vol. 125, no. 5, pp. 292-295 (In Russian).
9. Fedyanin M. Yu., Artamonova E. V., Barsukov Yu. A., Bolotina L. V., Gladkov O. A., Glebovskaya V. V., Gordeev S. S., Karachun A. M., Kozlov N. A., Lyubchenko L. N., Malikhova O. A., Mamedli Z. Z., Mikhaylov A. I., Podluzhnyy D. V., Protsenko S. A., Rybakov E. G., Rykov I. V., Samsonov D. V., Sidorov D. V., Snegovoy A. V., Tkachev S. I., Tryakin A. A., Tsukanov A. S., Chernykh M. V., Shelygin Yu. A. Practical recommendations for drug treatment of rectal cancer. Zlokachestvennye opykholi: Prakticheskie rek-omendatsii RUSSCO#3s2 – Malignant Tumours: Practical Recommendations of RUSSCO#3s2, 2020, vol. 10, pp. 391-438 (In Russian).
10. Aubakirov M.I., Dobrygina M.A., Krasnyh A.A., Miloichikova I.A., Stakhova O.M., Startseva Zh.A., Turgunova N.D. Assessment of dose loads of postoperative combined course of radiation therapy for endo-metrial cancer. Fundamental'naya i klinicheskaya onkologiya: dostizheniya i perspektivy razvitiya – Funda-mental and Clinical Oncology: Achievements and Development Prospects, 2019, pp. 16-20. (In Russian).
11. Stolbovoy A.V., Zalyalov I.F. Radiobiological models and clinical radiation oncology. Onkologiya. Zhurnal im. P.A. Gertsena – P.A. Herzen Journal of Oncology, 2016, vol. 5, no. 6, p. 88-96. DOI: 10.17116/onkolog20165688-96. (In Russian).
12. Ratner T.G., Kancheli I.A., Eluzhenkova K.A., Yur’yeva T.V. Clinical use of dose-volume histograms. Meditsinskaya fizika – Medical Physics, 2006, no. 1, pp. 73-81. (In Russian).
13. Marks L.B., Yorke E.D., Jackson A., Ten Haken R.K., Constine L.S., Eisbruch A., Deasy J.O. Use of normal tissue complication probability models in the clinic. Int. J. Radiat. Oncol. Biol. Phys., 2010, vol. 76, no. 3, pp. S10-S19. DOI: 10.1016/j.ijrobp.2009.07.1754.
14. Kehwar T.S. Analytical approach to estimate normal tissue complication probability using best fit of normal tissue tolerance doses into the NTCP equation of the linear quadratic model. J. Cancer Res. Ther., 2005, vol. 1, no. 3, ph. 168-179. DOI: 10.4103/0973-1482.19597.
15. Cox J.D., Stetz J.A., Pajak T.F. Toxicity criteria of the radiation therapy oncology group (RTOG) and the European organization for research and treatment of cancer (EORTC). Int. J. Radiat. Oncol. Biol. Phys., 1995, vol. 31, pp. 1341-1346. DOI:10.1016/0360-3016(95)00060-C.
Full-text article (in Russian)